What Happened?
Winston-Salem, NC-based Clinical ink Appointed Andrew Kraus as Chief Technology Officer
About the Company
Clinical ink is the global life science company that brings data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.
About the Person
Andrew Kraus is Chief Technology Officer at Clinical ink. Previously, Andrew held various senior IT leadership roles in the industry.
Info Source
Press Release
Short Profile